These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 35693394)
1. Risk factors for non-alcoholic fatty liver disease delineate the battlegrounds in optimizing disease prevention. Spivak I; Elinav E Hepatobiliary Surg Nutr; 2022 Jun; 11(3):492-494. PubMed ID: 35693394 [No Abstract] [Full Text] [Related]
2. Non-Alcoholic Fatty Liver Disease in HIV Infection. Macías J; Pineda JA; Real LM AIDS Rev; 2017; 19(1):35-46. PubMed ID: 28182612 [TBL] [Abstract][Full Text] [Related]
3. Multicausality in fatty liver disease: is there a rationale to distinguish between alcoholic and non-alcoholic origin? Völzke H World J Gastroenterol; 2012 Jul; 18(27):3492-501. PubMed ID: 22826613 [TBL] [Abstract][Full Text] [Related]
4. Dorothy Hodgkin Lecture 2012: non-alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management. Byrne CD Diabet Med; 2012 Sep; 29(9):1098-107. PubMed ID: 22672330 [TBL] [Abstract][Full Text] [Related]
5. The epidemiology of non-alcoholic fatty liver disease and its connection with cardiovascular disease: role of endothelial dysfunction. Federico A; Dallio M; Masarone M; Persico M; Loguercio C Eur Rev Med Pharmacol Sci; 2016 Nov; 20(22):4731-4741. PubMed ID: 27906428 [TBL] [Abstract][Full Text] [Related]
6. Treatment options for alcoholic and non-alcoholic fatty liver disease: A review. Singh S; Osna NA; Kharbanda KK World J Gastroenterol; 2017 Sep; 23(36):6549-6570. PubMed ID: 29085205 [TBL] [Abstract][Full Text] [Related]
7. Factors predicting non-alcoholic steatohepatitis (NASH) and advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD). Tasneem AA; Luck NH; Majid Z Trop Doct; 2018 Apr; 48(2):107-112. PubMed ID: 29145775 [TBL] [Abstract][Full Text] [Related]
8. Positive association of nap duration with risk of non-alcoholic fatty liver disease in an occupational population in Guangdong Province, China: a cross-sectional study. Hong C; Wu C; Ma P; Cui H; Chen L; Li R; Li Q; Zeng L; Liao S; Xiao L; Liu L; Li W BMC Gastroenterol; 2022 Apr; 22(1):185. PubMed ID: 35413791 [TBL] [Abstract][Full Text] [Related]
14. Factors that predict the occurrence of and recovery from non-alcoholic fatty liver disease after pancreatoduodenectomy. Sato T; Matsuo Y; Shiga K; Morimoto M; Miyai H; Takeyama H Surgery; 2016 Aug; 160(2):318-30. PubMed ID: 27211602 [TBL] [Abstract][Full Text] [Related]
15. Nonalcoholic fatty pancreatic disease and cardio-metabolic risk: is there is a place for obstructive sleep apnea? Mirrakhimov AE Cardiovasc Diabetol; 2014 Jan; 13():29. PubMed ID: 24475948 [TBL] [Abstract][Full Text] [Related]
16. Causes of Mortality in Non-Alcoholic Fatty Liver Disease (NAFLD) and Alcohol Related Fatty Liver Disease (AFLD). Johnston MP; Patel J; Byrne CD Curr Pharm Des; 2020; 26(10):1079-1092. PubMed ID: 32003662 [TBL] [Abstract][Full Text] [Related]
17. Increased risk of non-alcoholic fatty liver disease after diagnosis of celiac disease. Reilly NR; Lebwohl B; Hultcrantz R; Green PH; Ludvigsson JF J Hepatol; 2015 Jun; 62(6):1405-11. PubMed ID: 25617505 [TBL] [Abstract][Full Text] [Related]
18. Increased prevalence and risk of non-alcoholic fatty liver disease in overweight and obese patients with Type 2 diabetes in South China. Yi M; Chen RP; Yang R; Chen H Diabet Med; 2017 Apr; 34(4):505-513. PubMed ID: 27334577 [TBL] [Abstract][Full Text] [Related]